Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis-A post hoc analysis of the LANDMARK study.

Kiryu YoshidaTakuya MizukamiMasafumi Fukagawa Tadao AkizawaHokuto MorohoshiTakehiko SambeAkiko TakeshimaHidetoshi ItoHiroaki OgataNaoki Uchida

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2022)

The use of VDRA does not reduce the risks of cardiovascular events or all-cause mortality in patients on dialysis with well-controlled secondary hyperparathyroidism.

Keyphrases

cardiovascular events
end stage renal disease
chronic kidney disease
peritoneal dialysis
coronary artery disease
newly diagnosed
ejection fraction
cardiovascular disease
prognostic factors
patient reported outcomes
climate change
patient reported